Dec 14 (Reuters) - MEDIOS AG ILM1k.DE :
* PLANNED TAKEOVER OF NEWCO PHARMA GROUP APPROVED BY CARTEL
OFFICE
* CLOSING OF TRANSACTION IS PLANNED FOR Q1 OF 2022
* ACQUISITION OF NEWCO PHARMA ENABLES MEDIOS TO
SIGNIFICANTLY
STRENGTHEN IN PARTICULAR SEGMENT OF PATIENT-SPECIFIC THERAPIES
AND THUS ALSO TO SIGNIFICANTLY AND SUSTAINABLY INCREASE PROFIT
MARGINS OF ENTIRE MEDIOS GROUP
* TOGETHER WITH NEWCO PHARMA, MEDIOS AIMS TO EXCEED
1.5-BILLION-EURO REVENUE MARK IN 2022 AND SIGNIFICANTLY INCREASE
ITS EBITDA PRE^1 MARGIN TO OVER 3%
Source text for Eikon: ID:nEQ9MzqxWa
Further company coverage: ILM1k.DE
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))